Cargando…
Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion
BACKGROUND: ERG rearrangements and PTEN loss are two of the most common genetic alterations in prostate cancer. However, there is still significant controversy regarding the order of events of these two changes during the carcinogenic process. We used IHC to determine ERG and PTEN status and calcula...
Autores principales: | Gumuskaya, Berrak, Gurel, Bora, Fedor, Helen, Tan, Hsueh-Li, Weier, Christopher A., Hicks, Jessica L., Haffner, Michael C., Lotan, Tamara L., Marzo, Angelo M. De |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774596/ https://www.ncbi.nlm.nih.gov/pubmed/23545904 http://dx.doi.org/10.1038/pcan.2013.8 |
Ejemplares similares
-
Cytoplasmic PTEN Protein Loss Distinguishes Intraductal Carcinoma of the Prostate from High Grade Prostatic Intraepithelial Neoplasia
por: Lotan, Tamara L., et al.
Publicado: (2012) -
PTEN loss and chromosome 8 alterations in Gleason grade 3 prostate cancer cores predicts the presence of un-sampled grade 4 tumor: implications for Active Surveillance
por: Trock, Bruce J., et al.
Publicado: (2016) -
VEGF: A critical driver for angiogenesis and subsequent tumor growth: An IHC study
por: Kapoor, Prakhar, et al.
Publicado: (2012) -
Docetaxel Treatment in PTEN- and ERG-aberrant Metastatic Prostate Cancers
por: Rescigno, Pasquale, et al.
Publicado: (2018) -
Novel Dual Color Immunohistochemical methods for detecting ERG-PTEN and ERG-SPINK1 status in prostate carcinoma
por: Bhalla, Ritu, et al.
Publicado: (2013)